1,581 results on '"Ravaud A."'
Search Results
2. Cost-effectiveness of avelumab first-line maintenance therapy for adult patients with locally advanced or metastatic urothelial carcinoma in France
3. Rationale and design of the FRENch CoHort of myocardial Infarction Evaluation (FRENCHIE) study
4. V04-12 LEVEL 2 VENA CAVA THROMBECTOMY AND ROBOT ASSISTED RADICAL NEPHRECTOMY FOLLOWING IMMUNOTHERAPY
5. Psychometric Properties and Domains Covered by Patient-Reported Outcome Measures Used in Trials Assessing Interventions for Chronic Pain
6. ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma
7. Compelling evidence from meta-epidemiological studies demonstrates overestimation of effects in randomized trials that fail to optimize randomization and blind patients and outcome assessors
8. Five principles for the development of minimally disruptive digital medicine
9. Validation internationale des domaines d’évaluation des neurofibromes cutanés dans la neurofibromatose de type 1
10. Essai randomisé, contrôle et en double aveugle sur l’impact de la rosuvastatine sur les marqueurs d’athérosclérose infra-clinique chez les patients atteints de vascularite associée aux ANCA
11. Initiation d’un anti-TNF chez les patients atteints de polyarthrite rhumatoïde : données à l’inclusion issues du registre national ART-SFR
12. Chapitre 2. L’ère du handicap : vers une politique unificatrice, les « trente glorieuses » (1945-1975)
13. Chapitre 6. Familles, sexualités, procréation
14. Chapitre 1. La longue genèse d’une notion récente
15. Chapitre 3. Au tournant du XXIe siècle : vers une ère des droits et de la citoyenneté ?
16. Chapitre 4. Expérience du handicap
17. Chapitre 7. Les âges de la vie : éducation, travail et vieillissement
18. Chapitre 5. Mobilisations et action collective
19. Clinical and Biological Differences between Upper Tract Carcinoma and Bladder Urothelial Cancer, Including Implications for Clinical Practice
20. More rapid blood interferon α2 decline in fatal versus surviving COVID-19 patients
21. cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults
22. Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma
23. X-ray and Infrared Microanalyses of Mona Lisa’s Ground Layer and Significance Regarding Leonardo da Vinci’s Palette
24. Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial
25. Biomedical doctoral students’ research practices when facing dilemmas: two vignette-based randomized control trials
26. Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry
27. Colourless Powdered Glass as a Drier for Red Lakes: On the Influence of Composition and Particle Size
28. Level 2 vena cava thrombectomy and robot assisted radical nephrectomy following immunotherapy
29. Assessment of US Food and Drug Administration–Approved Digital Medical Devices for Just-in-Time Interventions
30. Silicification of trilobites and biofilm from the Cambrian Weeks Formation, Utah: Evidence for microbial mediation of silicification: REPLY
31. Trajectories of the evolution of post-COVID-19 condition, up to two years after symptoms onset
32. Does adipose tissue contribute to acute infection-related inflammation in COVID-19?
33. Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
34. A methodological framework allows the identification of personomic markers to consider when designing personalized interventions
35. Coupling numerical and experimental methods to characterise the mechanical behaviour of the Mona Lisa: a method to enhance the conservation of panel paintings
36. Reminding Peer Reviewers of Reporting Guideline Items to Improve Completeness in Published Articles
37. Interleukin-6 blocking agents for treating COVID-19: a living systematic review
38. POS0182 RISK-BENEFIT ASSESSMENT OF THE USE OF RITUXIMAB FOR RHEUMATOID ARTHRITIS IN REAL LIFE: FINDINGS FROM 1984 PATIENTS FROM THE FRENCH AUTOIMMUNITY AND RITUXIMAB REGISTRY
39. Sharing of Individual Patient-Level Data by Trialists of Randomized Clinical Trials of Pharmacological Treatments for COVID-19
40. First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma
41. Influence of the addition of crushed glass on the physical and chemical properties of lead white oil paint
42. Crystal structure of DltE from L. plantarum, TCEP form
43. Crystal structure of DltE from L. plantarum, apo form
44. Crystal structure of DltE from L. plantarum, tartare bound form
45. Structure–function analysis of Lactiplantibacillus plantarum DltE reveals D-alanylated lipoteichoic acids as direct cues supporting Drosophila juvenile growth
46. Patients' Perspectives on How to Improve Endometriosis Care: A Large Qualitative Study Within the ComPaRe-Endometriosis e-Cohort
47. Supplementary Figure Legends from Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas
48. Supplemental Figure S3 from Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas
49. Supplementary Figure S1 from Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib
50. Supplemental Figure S6 from Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.